Elevate your local knowledge
Sign up for the iNFOnews newsletter today!

WOONSOCKET, R.I. – CVS Caremark says its first-quarter earnings jumped 18 per cent as generic drugs and an acquisition helped the drugstore and pharmacy benefits manager weather rough winter storms and a later Easter holiday.
It topped profit and revenue expectations, sending shares higher in premarket trading Friday.
The Woonsocket company reaffirmed its 2014 forecast for adjusted earnings of between $4.36 and $4.50 per share.
CVS Caremark Corp. earned $1.13 billion, or 95 cents per share. That compares with earnings of $954 million, or 77 cents per share, in last year’s quarter. Revenue climbed 6 per cent to $32.69 billion.
Adjusted results totalled $1.02 per share.
Analysts expect earnings of $1.04 per share on about $32.3 billion in revenue.
Generic drugs have improved the profitability of drugstore operators like CVS Caremark for several quarters.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.